TALVEY — Sales to customers (Note 9)
Products & Services · Sales to customers (Note 9)Johnson & Johnson TALVEY — Sales to customers (Note 9) increased by 15.1% to $244.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 61.6%, from $151.00M to $244.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ3 2025
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market demand and successful commercialization of the product, while a decrease may signal competitive pressure or market saturation.
Detailed definition
This metric represents the total net revenue generated from the sale of the TALVEY product line to external customers du...
Peer comparison
Comparable to product-specific revenue disclosures found in the segment reporting of other large-cap pharmaceutical companies.
Metric ID:
jnj_segment_talvey_sales_to_customers_note_9Historical Data
6 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $116.00M | $137.00M | $151.00M | $172.00M | $212.00M | $244.00M |
| QoQ Change | — | +18.1% | +10.2% | +13.9% | +23.3% | +15.1% |
| YoY Change | — | — | — | +48.3% | +54.7% | +61.6% |
Range$116.00M – $244.00M
CAGR+81.3%
Avg YoY Growth+54.9%
Median YoY Growth+54.7%
Current Streak5+ quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's talvey — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported talvey — sales to customers (note 9) of $244.00M in Q3 2025.
- How has Johnson & Johnson's talvey — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's talvey — sales to customers (note 9) increased by 61.6% year-over-year, from $151.00M to $244.00M.
- What does talvey — sales to customers (note 9) mean?
- The total revenue earned from selling the TALVEY product to customers.